USB002

· US Biotest, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for USB002, covering 2023-12-01 to 2023-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 [Phase 2]